Myelin basic protein-specific CD4+ cytolytic T-lymphocyte clones isolated from multiple sclerosis patients

Area of Science:

• Neuroimmunology
• Cellular immunology
• Autoimmunity

Background:

• Multiple Sclerosis (MS) is an autoimmune disease targeting the central nervous system.
• Myelin basic protein (MBP) is a key autoantigen implicated in MS pathogenesis.
• Understanding T-cell responses to MBP is crucial for MS research.

Purpose of the Study:

• To isolate and characterize stable, long-term human T-lymphocyte clones specific for MBP from MS patients.
• To investigate the functional capabilities of these MBP-specific T-cell clones.

Main Methods:

• Peripheral blood mononuclear cells from MS patients were cultured using limiting dilution with MBP, autologous irradiated cells, and Interleukin-2 (IL-2).
• T-cell clones were characterized for phenotype (CD4+).
• Cytolytic activity was assessed using 51Chromium-labeled autologous Epstein-Barr virus (EBV)-transformed B-cells as targets.
• Interleukin-2 production was measured upon stimulation.

Main Results:

• Stable, long-term human T-lymphocyte clones specific for MBP were successfully isolated from MS patients.
• All isolated clones exhibited the CD4+ phenotype.
• A majority of clones displayed MBP-specific cytolytic activity.
• Some clones possessed natural killer (NK) function.
• All clones produced Interleukin-2 (IL-2) when adequately stimulated.

Conclusions:

• The study successfully established MBP-specific T-cell clones from MS patients, providing valuable tools for further research.
• These CD4+ T-cell clones demonstrate functional effector mechanisms, including cytolysis and IL-2 production, relevant to MS.
• The isolation method effectively minimized suppressor cell activity, enabling the characterization of pathogenic T-cell responses.